[7] |
Lenz ER, Pugh LC, Milligan RA, et al. The middle-range theory of unpleasant symptoms:an update[J]. ANS Adv Nurs Sci, 1997,19(3):14-27.
|
[8] |
Smith MJ, Liehr PR. Middle range theory for nursing[M]. New York: Springer Publishing Company, 2013: 179.
|
[9] |
Kline RB. Principles and practice of structural equation modeling[M]. New York: The Guilford Press, 2015: 16.
|
[10] |
Kroenke K, Spitzer RL, Williams JB. The PHQ-9:validity of a brief depression severity measure[J]. J Gen Intern Med, 2001,16(9):606-613.
|
[11] |
Wang WZ, Bian Q, Zhao Y, et al. Reliability and validity of the Chinese version of the Patient Health Questionnaire(PHQ-9) in the general population[J]. Gen Hosp Psychiatry, 2014,36(5):539-544.
|
[12] |
Zimet GD, Dahlem NW, Zimet SG, et al. The multidimensional scale of perceived social support[J]. J Pers Assess, 1988,52(1):30-41.
|
[13] |
姜乾金. 领悟社会支持量表[J]. 中国行为医学科学, 2001,10(10):41-43.
|
[14] |
Tofthagen CS, McMillan SC, Kip KE. Development and psychometric evaluation of the chemotherapy-induced peripheral neuropathy assessment tool[J]. Cancer Nurs, 2011,34(4):E10-E20.
|
[15] |
Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy scale:development and validation of the general measure[J]. J Clin Oncol, 1993,11(3):570-579.
pmid: 8445433
|
[16] |
Cheung YB, Goh C, Wee J, et al. Measurement properties of the Chinese language version of the functional assessment of cancer therapy-general in a Singaporean population[J]. Ann Acad Med Singap, 2009,38(3):225-229.
|
[17] |
吴明隆. 结构方程模型:AMOS的操作与应用[M]. 重庆: 重庆大学出版社, 2009.
|
[18] |
顾芳红, 周建伟, 谢立芳. 清燥救肺汤加减对晚期非小细胞肺癌化疗患者生活质量和生存期的影响[J]. 中国实验方剂学杂志, 2020,26(11):142-147.
|
[19] |
夏为书. 宫颈癌患者同步放化疗期间的症状群与生活质量的相关性研究[D]. 南昌:南昌大学, 2019.
|
[20] |
唐磊, 强万敏, 王盈, 等. 癌症患者生活质量影响因素的研究现状[J]. 护士进修杂志, 2019,34(11):985-987.
|
[1] |
Padmaja G, Vanlalhruaii C, Rana S, et al. Quality of life of pa-tients with cancer:a determinant of the quality of life of their family caregivers[J]. J Cancer Educ, 2017,32(3):655-661.
|
[2] |
Stubblefield MD, Burstein HJ, Burton AW, et al. NCCN task force report:management of neuropathy in cancer[J]. J Natl Compr Canc Netw, 2009, 7(Suppl 5):S1-S26;quiz S27-8.
|
[21] |
房宁宁, 付菊芳, 陈协群, 等. 白血病患者化疗期间的生活质量及其影响因素[J]. 解放军护理杂志, 2014,31(4):1-5.
|
[3] |
Argyriou AA, Bruna J, Anastopoulou GG, et al. Assessing risk factors of falls in cancer patients with chemotherapy-induced peripheral neurotoxicity[J]. Support Care Cancer, 2020,28(4):1991-1995.
|
[22] |
Han SS, Han JW. The influences of depression,anxiety,social support and knowledge of anticancer drugs on the chemotherapy-induced peripheral neuropathy among colorectal cancer patients receiving oxaliplatin[J]. Journal of Korean Clinical Nursing Research, 2013,19(2):298-308.
|
[4] |
Staff NP, Grisold A, Grisold W, et al. Chemotherapy-induced peri-pheral neuropathy:a current review[J]. Ann Neurol, 2017,81(6):772-781.
|
[23] |
Nielsen AM, Welch WA, Gavin KL, et al. Preferences for mHealth physical activity interventions during chemotherapy for breast cancer:a qualitative evaluation[J]. Support Care Cancer, 2020,28(4):1919-1928.
|
[5] |
洪悦颖, 徐晨, 于海燕, 等. 癌症患者化疗所致周围神经病变及影响因素分析[J]. 中华护理教育, 2019,16(12):892-896.
|
[24] |
Kanda K, Fujimoto K, Kyota A. Emotional responses to persistent chemotherapy-induced peripheral neuropathy experienced by patients with colorectal cancer in Japan[J]. Asia Pac J Oncol Nurs, 2017,4(3):233-240.
doi: 10.4103/apjon.apjon_12_17
pmid: 28695170
|
[6] |
Yoon YJ, Park JS. Factors influencing peripheral neuropathy of cancer patients undergoing chemotherapy[J]. Asian Oncol Nurs, 2019,19(2):71-80.
|
[7] |
Lenz ER, Pugh LC, Milligan RA, et al. The middle-range theory of unpleasant symptoms:an update[J]. ANS Adv Nurs Sci, 1997,19(3):14-27.
|
[8] |
Smith MJ, Liehr PR. Middle range theory for nursing[M]. New York: Springer Publishing Company, 2013: 179.
|
[9] |
Kline RB. Principles and practice of structural equation modeling[M]. New York: The Guilford Press, 2015: 16.
|
[10] |
Kroenke K, Spitzer RL, Williams JB. The PHQ-9:validity of a brief depression severity measure[J]. J Gen Intern Med, 2001,16(9):606-613.
|
[11] |
Wang WZ, Bian Q, Zhao Y, et al. Reliability and validity of the Chinese version of the Patient Health Questionnaire(PHQ-9) in the general population[J]. Gen Hosp Psychiatry, 2014,36(5):539-544.
|
[12] |
Zimet GD, Dahlem NW, Zimet SG, et al. The multidimensional scale of perceived social support[J]. J Pers Assess, 1988,52(1):30-41.
|
[13] |
姜乾金. 领悟社会支持量表[J]. 中国行为医学科学, 2001,10(10):41-43.
|
[14] |
Tofthagen CS, McMillan SC, Kip KE. Development and psychometric evaluation of the chemotherapy-induced peripheral neuropathy assessment tool[J]. Cancer Nurs, 2011,34(4):E10-E20.
|
[15] |
Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy scale:development and validation of the general measure[J]. J Clin Oncol, 1993,11(3):570-579.
pmid: 8445433
|
[16] |
Cheung YB, Goh C, Wee J, et al. Measurement properties of the Chinese language version of the functional assessment of cancer therapy-general in a Singaporean population[J]. Ann Acad Med Singap, 2009,38(3):225-229.
|
[17] |
吴明隆. 结构方程模型:AMOS的操作与应用[M]. 重庆: 重庆大学出版社, 2009.
|
[18] |
顾芳红, 周建伟, 谢立芳. 清燥救肺汤加减对晚期非小细胞肺癌化疗患者生活质量和生存期的影响[J]. 中国实验方剂学杂志, 2020,26(11):142-147.
|
[19] |
夏为书. 宫颈癌患者同步放化疗期间的症状群与生活质量的相关性研究[D]. 南昌:南昌大学, 2019.
|
[20] |
唐磊, 强万敏, 王盈, 等. 癌症患者生活质量影响因素的研究现状[J]. 护士进修杂志, 2019,34(11):985-987.
|
[21] |
房宁宁, 付菊芳, 陈协群, 等. 白血病患者化疗期间的生活质量及其影响因素[J]. 解放军护理杂志, 2014,31(4):1-5.
|
[22] |
Han SS, Han JW. The influences of depression,anxiety,social support and knowledge of anticancer drugs on the chemotherapy-induced peripheral neuropathy among colorectal cancer patients receiving oxaliplatin[J]. Journal of Korean Clinical Nursing Research, 2013,19(2):298-308.
|
[23] |
Nielsen AM, Welch WA, Gavin KL, et al. Preferences for mHealth physical activity interventions during chemotherapy for breast cancer:a qualitative evaluation[J]. Support Care Cancer, 2020,28(4):1919-1928.
|
[24] |
Kanda K, Fujimoto K, Kyota A. Emotional responses to persistent chemotherapy-induced peripheral neuropathy experienced by patients with colorectal cancer in Japan[J]. Asia Pac J Oncol Nurs, 2017,4(3):233-240.
doi: 10.4103/apjon.apjon_12_17
pmid: 28695170
|